BD X-20 LSRFortessa
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- tbd@fda.gov
- Joshua Holliday joshua.holliday@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting a new contract requirement for the BD X-20 LSRFortessa, an analytical laboratory instrument, with an estimated solicitation release date of July 1, 2026, and an anticipated award date of September 1, 2026. The procurement falls under the Analytical Laboratory Instrument Manufacturing NAICS code 334516, indicating a specialized scientific equipment acquisition. This forecast suggests the FDA is seeking to procure advanced laboratory instrumentation to support its research and regulatory testing capabilities.
While specific award values and detailed contract specifications are not provided, the contract opportunity involves a direct procurement without a specific set-aside designation. Potential vendors should note the key contacts are Joshua Holliday (joshua.holliday@fda.hhs.gov) from the FDA and a TBD mailbox contact (tbd@fda.gov). The procurement is directly associated with the Department of Health and Human Services Food and Drug Administration, implying the equipment will likely be used in federal research, testing, or regulatory environments.
Forecast text
BD X-20 LSRFortessa; this is probably not the same as the X-20
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast